Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cristina Meazza & Paolo Scanagatta. (2016) Metastatic osteosarcoma: a challenging multidisciplinary treatment. Expert Review of Anticancer Therapy 16:5, pages 543-556.
Read now
Read now
William S. Ferguson & Allen M. Goorin. (2001) Current Treatment of Osteosarcoma. Cancer Investigation 19:3, pages 292-315.
Read now
Read now
Articles from other publishers (29)
Jonathan B. Mandell, Nerone Douglas, Vrutika Ukani, Jan H. Beumer, Jianxia Guo, John Payne, Rebecca Newman, Luigi Mancinelli, Giuseppe Intini, Carolyn J. Anderson, Rebecca Watters & Kurt Weiss. (2022) ALDH1A1 Gene Expression and Cellular Copper Levels between Low and Highly Metastatic Osteosarcoma Provide a Case for Novel Repurposing with Disulfiram and Copper. Sarcoma 2022, pages 1-12.
Crossref
Crossref
Jonathan B. Mandell, Feiqi Lu, Matthew Fisch, Jan H. Beumer, Jianxia Guo, Rebecca J. Watters & Kurt R. Weiss. (2019)
Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma:
In Vitro
Support for a Novel Drug Repurposing Strategy
. Sarcoma 2019, pages 1-9.
Crossref
Crossref
Colleen M. Costelloe, Hubert H. Chuang & Najat C. Daw. (2017) PET/CT of Osteosarcoma and Ewing Sarcoma. Seminars in Roentgenology 52:4, pages 255-268.
Crossref
Crossref
Andrea Angelini, Andreas F. Mavrogenis, Giulia Trovarelli, Stefano Ferrari, Piero Picci & Pietro Ruggieri. (2016) Telangiectatic osteosarcoma: a review of 87 cases. Journal of Cancer Research and Clinical Oncology 142:10, pages 2197-2207.
Crossref
Crossref
Yasunori Tome, Hiroaki Kimura, Tasuku Kiyuna, Naotoshi Sugimoto, Hiroyuki Tsuchiya, Fuminori Kanaya, Michael Bouvet & Robert M. Hoffman. (2016)
Disintegrin targeting of an αvβ3 integrin-over-expressing high-metastatic human osteosarcoma with echistatin inhibits cell proliferation, migration, invasion and adhesion
in vitro
. Oncotarget 7:29, pages 46315-46320.
Crossref
Crossref
Xiaodong Mu, Daniel Brynien & Kurt R. Weiss. (2015)
The HDAC Inhibitor Vorinostat Diminishes the
In Vitro
Metastatic Behavior of Osteosarcoma Cells
. BioMed Research International 2015, pages 1-6.
Crossref
Crossref
Daliu Min, Feng Lin, Zan Shen, Shuier Zheng, Lina Tan, Wenxi Yu & Yang Yao. (2013) Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy. Asia-Pacific Journal of Clinical Oncology 9:1, pages 71-79.
Crossref
Crossref
Sue C. KasteGeorge L. WaszilycsakM. Beth McCarvilleNajat C. Daw. (2010)
Estimation of Potential Excess Cancer Incidence in Pediatric
201
Tl Imaging
. American Journal of Roentgenology 194:1, pages 245-249.
Crossref
Crossref
Hiroaki Kimura, Hiroyuki Tsuchiya, Toshiharu Shirai, Hideji Nishida, Katsuhiro Hayashi, Akihiko Takeuchi, Issei Ohnari & Katsuro Tomita. (2009) Caffeine-potentiated chemotherapy for metastatic osteosarcoma. Journal of Orthopaedic Science 14:5, pages 556-565.
Crossref
Crossref
P. K. Wu, W. M. Chen, C. F. Chen, O. K. Lee, C. K. Haung & T. H. Chen. (2009) Primary Osteogenic Sarcoma with Pulmonary Metastasis: Clinical Results and Prognostic Factors in 91 Patients. Japanese Journal of Clinical Oncology 39:8, pages 514-522.
Crossref
Crossref
Terrence Jose Jerome, Mathew Varghese, Balu Sankaran, Simon Thomas & S.K. Thirumagal. (2009) Tibial Chondroblastic Osteosarcoma—Case Report. Foot and Ankle Surgery 15:1, pages 33-39.
Crossref
Crossref
Klaus-Dieter Diemel, Heinz-Jürgen Klippe & Detlev Branscheid. 2009. Treatment of Bone and Soft Tissue Sarcomas. Treatment of Bone and Soft Tissue Sarcomas
183
208
.
Emanuela Palmerini, Eric L Staals, Stefano Ferrari, Raffaella Rinaldi, Marco Alberghini, Mario Mercuri & Gaetano Bacci. (2008) Nonresectable Multiple Lung Metastases of High-Grade Osteosarcoma of the Humerus: Stable After Twelve Years. The Journal of Bone and Joint Surgery-American Volume 90:10, pages 2240-2244.
Crossref
Crossref
Tim IllidgeStephen Lowis, Eddy Estlin & Keith Sibson. 2008. Treatment of Cancer Fifth Edition. Treatment of Cancer Fifth Edition
1118
1166
.
Kurt R Weiss, Gregory M Cooper, Julie A Jadlowiec, Richard L McGoughIIIIII & Johnny Huard. (2006) VEGF and BMP Expression in Mouse Osteosarcoma Cells. Clinical Orthopaedics and Related Research 450, pages 111-117.
Crossref
Crossref
Patrick J. Leavey, Charles Timmons, William Frawley, Donald Lombardi & Raheela Ashfaq. (2006) KAI-1 Expression in Pediatric High-Grade Osteosarcoma. Pediatric and Developmental Pathology 9:3, pages 219-224.
Crossref
Crossref
Joerg Thomas Hartmann & Hans-Georg Kopp. (2006) Bone sarcomas. Update on Cancer Therapeutics 1:1, pages 65-74.
Crossref
Crossref
Najat C. Daw, Catherine A. Billups, Carlos Rodriguez-Galindo, M. Beth McCarville, Bhaskar N. Rao, Alvida M. Cain, Jesse J. Jenkins, Michael D. Neel & William H. Meyer. (2006) Metastatic osteosarcoma. Cancer 106:2, pages 403-412.
Crossref
Crossref
Axel Stäbler. 2005. Handbuch diagnostische Radiologie. Handbuch diagnostische Radiologie
170
211
.
Wendy T Su, Joseph Chewning, Sara Abramson, Nancy Rosen, Maryam Gholizadeh, John Healey, Paul Meyers & Michael P La Quaglia. (2004) Surgical management and outcome of osteosarcoma patients with unilateral pulmonary metastases. Journal of Pediatric Surgery 39:3, pages 418-423.
Crossref
Crossref
Holly Zhou, R. Lor Randall, Arthur R. Brothman, Teresa Maxwell, Cheryl M. Coffin & Robert E. Goldsby. (2003) HER-2/ neu Expression in Osteosarcoma Increases Risk of Lung Metastasis and Can Be Associated With Gene Amplification. Journal of Pediatric Hematology/Oncology 25:1, pages 27-32.
Crossref
Crossref
Roby C. ThompsonJrJr, Edward Y. Cheng, Denis R. Clohisy, John Perentesis, Carlos Manivel & Chap T. Le. (2002) Results of Treatment for Metastatic Osteosarcoma With Neoadjuvant Chemotherapy and Surgery. Clinical Orthopaedics and Related Research 397, pages 240-247.
Crossref
Crossref
Stefan S. BielackBeate Kempf-BielackGünter DellingG. Ulrich ExnerSilke FlegeKnut HelmkeRainer KotzMechthild Salzer-KuntschikMatthias WernerWinfried WinkelmannAndreas ZoubekHeribert JürgensKurt Winkler. (2002) Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols. Journal of Clinical Oncology 20:3, pages 776-790.
Crossref
Crossref
Kazuhiro Tanaka, Aiko Katayama, Akio Sakamoto, Shuichi Matsuda, Yukihide Iwamoto, Hirokazu Chuman & Noriko Urano. (2002) Treatment of Chemosensitive-Sarcoma Patients with Metastases at Diagnosis: Possible Prognostic Value of Peripheral Blood Stem Cell Transplantation.. Orthopedics & Traumatology 51:4, pages 860-864.
Crossref
Crossref
Joe B. PutnamJrJr. (2002) New and evolving treatment methods for pulmonary metastases. Seminars in Thoracic and Cardiovascular Surgery 14:1, pages 49-56.
Crossref
Crossref
Nalan Gokgoz, Jay S. Wunder, Spyro Mousses, Sasha Eskandarian, Robert S. Bell & Irene L. Andrulis. (2001) Comparison ofp53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma. Cancer 92:8, pages 2181-2189.
Crossref
Crossref
Malcolm A. Smith & Barry Anderson. (2001) Phase II Window Studies: 10 Years of Experience and Counting. Journal of Pediatric Hematology/Oncology 23:6, pages 334-337.
Crossref
Crossref
A.J.S. Renard, R.P.H. Veth, H.W.B. Schreuder, M. Pruszczynski, J.P.M. B�kkerink, Q.G.C.M. van Hoesel & F.J.M. van der Staak. (1999) Osteosarcoma: Oncologic and functional results. A single institutional report covering 22 years. Journal of Surgical Oncology 72:3, pages 124-129.
Crossref
Crossref
Carola A.S. Arndt & William M. Crist. (1999) Common Musculoskeletal Tumors of Childhood and Adolescence. New England Journal of Medicine 341:5, pages 342-352.
Crossref
Crossref